News
BDXB
48.16
0.00%
0.00
BD amends bylaws to update advance notice rules for contested elections
PUBT · 2d ago
BD declares quarterly dividend of $1.05 per share
PUBT · 3d ago
BD EVP, Chief Revenue Officer Michael Feld disposes of 74 shares for $11,243.56
PUBT · 3d ago
Incyte names Suketu Upadhyay CFO effective May 4, 2026
PUBT · 3d ago
BD partners with Suttons Creek on combination product development support for pharma, biotech
PUBT · 4d ago
U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon Mobil
Reuters · 04/17 07:36
Comprehensive Healthcare Systems names John C. Seguin vice president of sales
PUBT · 04/16 10:31
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
Reuters · 04/14 07:45
BD <BDX.N>: RBC CUTS TARGET PRICE TO $175 FROM $195
Reuters · 04/14 04:12
BD to webcast fiscal Q2 results and business update
Reuters · 04/09 20:19
BD Interventional President Rick Byrd to retire in June
Reuters · 04/09 20:06
BD trial finds PureWick urine system improves sleep for women with nighttime incontinence
Reuters · 04/09 10:50
US FDA approves Waters' at‑home cervical cancer screening kit
Reuters · 04/08 13:23
BD wins EU CE mark for Liverty TIPS stent graft in portal hypertension care
Reuters · 04/08 10:50
BD launches Pyxis Pro AI-enabled medication dispensing system in Europe
Reuters · 04/01 09:01
BD EVP and General Counsel Lanesha Minnix files initial beneficial ownership statement
Reuters · 03/17 18:44
KORU Medical names Adam Kalbermatten CEO as Linda Tharby retires June 30, 2026
Reuters · 03/12 20:17
BD and Sinteco sign technology partnership for connected medication management in Europe
Reuters · 03/11 10:06
BECTON DICKINSON EXEC SAYS MIDDLE EAST EXPOSURE IS WITHIN 2% RANGE, ADDS REGION HAS BEEN A STRONG CONTRIBUTOR- BARCLAYS CONF
Reuters · 03/10 12:41
BECTON DICKINSON EXEC SAYS COMPANY WILL CONTINUE PURSUING TUCK‑IN M&A IN HIGH‑GROWTH AREAS – BARCLAYS CONF
Reuters · 03/10 12:41
More
Webull provides a variety of real-time BDXB stock news. You can receive the latest news about Becton Dickinson And Co through multiple platforms. This information may help you make smarter investment decisions.
About BDXB
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.